Anders Paul Wiklund

Plus aucun poste en cours

Profil

Anders Paul Wiklund is the founder of Esperion Therapeutics, Inc. (founded in 1998) and Wiklund International, Inc. (founded in 1997).
He held the title of Director at Esperion Therapeutics, Inc. and Principal at Wiklund International, Inc. In terms of former jobs, he was the President & Chief Executive Officer at Kabi Pharmacia, President & Chief Executive Officer at Kabivitrum, Inc., Chairman at Calliditas Therapeutics AB, Chairman at Weifa ASA, Chairman at Irras AB, and Director at InSite Vision, Inc., Sirna Therapeutics, Inc., Trega Biosciences, Inc., QuatRx Pharmaceuticals Co., GLYCODesign, Inc., Gyros AB, EffRx, Inc., Bioreason, Inc., Acureon Pharmaceuticals, Inc., EffRx Pharmaceuticals SA, Medivir AB, Inspirion Delivery Sciences LLC, and Life Medical Sweden AB. He was also the Managing Director at KabiVitrum Ltd. and Vice President at Pharmacia & Upjohn, Inc. He held the title of Principal at The Upjohn Co. and Pharmacia Corp.
He was the President at Pharmacia Development Co., Inc. and President at Kabivitrum AB. He was also the Head-Business Development at Biacore AB. He graduated from the University of Stockholm.

Anciens postes connus de Anders Paul Wiklund

Sociétés	Poste	Fin
IRRS ABNPV	Président	18/08/2020
EffRx Pharmaceuticals SA	Directeur/Membre du Conseil	18/08/2020
Life Medical Sweden AB	Directeur/Membre du Conseil	18/08/2020
Acureon Pharmaceuticals, Inc.	Directeur/Membre du Conseil	18/08/2020
Wiklund International, Inc.	Fondateur	18/08/2020